EdgarLookup

ARBOR REALTY TRUST INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that ARBOR REALTY TRUST INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
0%
Return on Assets
Net income ÷ assets
3.87x
Debt-to-Equity
Total liabilities ÷ equity

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2015 Dec 31, 2015 $6.91M Feb 26, 2016
FY2015 Sep 30, 2015 $17.23M Feb 26, 2016
FY2015 Jun 30, 2015 $12.39M Feb 26, 2016
FY2015 Mar 31, 2015 $16.90M Feb 26, 2016
FY2015 Dec 31, 2014 $6.94M Feb 26, 2016
FY2015 Sep 30, 2014 $65.29M Feb 26, 2016
FY2015 Jun 30, 2014 $13.35M Feb 26, 2016
FY2015 Mar 31, 2014 $7.47M Feb 26, 2016
FY2015 Dec 31, 2013 $21.30M Feb 26, 2016

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $176.61M Feb 27, 2026
FY2025 Dec 31, 2024 $297.40M Feb 27, 2026
FY2025 Dec 31, 2023 $427.90M Feb 27, 2026
FY2024 Dec 31, 2022 $371.31M Feb 21, 2025
FY2023 Dec 31, 2021 $424.09M Feb 20, 2024
FY2022 Dec 31, 2020 $236.55M Feb 17, 2023
FY2021 Dec 31, 2019 $170.27M Feb 18, 2022
FY2020 Dec 31, 2018 $157.78M Feb 19, 2021
FY2019 Dec 31, 2017 $110.87M Feb 14, 2020
FY2018 Dec 31, 2016 $43.62M Feb 15, 2019

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $59.81M Feb 27, 2026
FY2025 Dec 31, 2024 $54.93M Feb 27, 2026
FY2025 Dec 31, 2023 $51.26M Feb 27, 2026
FY2024 Dec 31, 2022 $53.99M Feb 21, 2025
FY2023 Dec 31, 2021 $45.58M Feb 20, 2024
FY2022 Dec 31, 2020 $37.35M Feb 17, 2023
FY2021 Dec 31, 2019 $40.33M Feb 18, 2022
FY2020 Dec 31, 2018 $37.07M Feb 19, 2021
FY2019 Dec 31, 2017 $30.74M Feb 14, 2020
FY2018 Dec 31, 2016 $17.59M Feb 15, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $372.38M Feb 27, 2026
FY2025 Dec 31, 2024 $461.52M Feb 27, 2026
FY2025 Dec 31, 2023 $235.86M Feb 27, 2026
FY2024 Dec 31, 2022 $1.10B Feb 21, 2025
FY2023 Dec 31, 2021 $216.85M Feb 20, 2024
FY2022 Dec 31, 2020 $55.17M Feb 17, 2023
FY2021 Dec 31, 2019 ($226.54M) Feb 18, 2022
FY2020 Dec 31, 2018 ($37.74M) Feb 19, 2021
FY2019 Dec 31, 2017 $459.70M Feb 14, 2020
FY2018 Dec 31, 2016 ($198.52M) Feb 15, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $14.49B Feb 27, 2026
FY2025 Dec 31, 2024 $13.49B Feb 27, 2026
FY2024 Dec 31, 2023 $15.74B Feb 21, 2025
FY2023 Dec 31, 2022 $17.04B Feb 20, 2024
FY2022 Dec 31, 2021 $15.07B Feb 17, 2023
FY2021 Dec 31, 2020 $7.66B Feb 18, 2022
FY2020 Dec 31, 2019 $6.24B Feb 19, 2021
FY2019 Dec 31, 2018 $4.61B Feb 14, 2020
FY2018 Dec 31, 2017 $3.63B Feb 15, 2019
FY2017 Dec 31, 2016 $2.97B Feb 23, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $11.43B Feb 27, 2026
FY2025 Dec 31, 2024 $10.34B Feb 27, 2026
FY2024 Dec 31, 2023 $12.48B Feb 21, 2025
FY2023 Dec 31, 2022 $13.97B Feb 20, 2024
FY2022 Dec 31, 2021 $12.52B Feb 17, 2023
FY2021 Dec 31, 2020 $6.18B Feb 18, 2022
FY2020 Dec 31, 2019 $4.88B Feb 19, 2021
FY2019 Dec 31, 2018 $3.55B Feb 14, 2020
FY2018 Dec 31, 2017 $2.76B Feb 15, 2019
FY2017 Dec 31, 2016 $2.22B Feb 23, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.95B Feb 27, 2026
FY2025 Dec 31, 2024 $3.02B Feb 27, 2026
FY2024 Dec 31, 2023 $3.12B Feb 21, 2025
FY2023 Dec 31, 2022 $2.94B Feb 20, 2024
FY2022 Dec 31, 2021 $2.42B Feb 17, 2023
FY2021 Dec 31, 2020 $1.34B Feb 18, 2022
FY2020 Dec 31, 2019 $1.18B Feb 19, 2021
FY2019 Dec 31, 2018 $895.24M Feb 14, 2020
FY2018 Dec 31, 2017 $695.83M Feb 15, 2019
FY2017 Dec 31, 2016 $587.14M Feb 23, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $56.60M Feb 27, 2026
FY2025 Dec 31, 2024 $56.60M Feb 27, 2026
FY2024 Dec 31, 2023 $56.60M Feb 21, 2025
FY2023 Dec 31, 2022 $56.60M Feb 20, 2024
FY2022 Dec 31, 2021 $56.60M Feb 17, 2023
FY2021 Dec 31, 2020 $56.60M Feb 18, 2022
FY2020 Dec 31, 2019 $56.60M Feb 19, 2021
FY2019 Dec 31, 2018 $56.60M Feb 14, 2020
FY2018 Dec 31, 2017 $56.63M Feb 15, 2019
FY2018 Dec 31, 2016 $26.75M Feb 15, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($136.60M) Feb 27, 2026
FY2025 Dec 31, 2024 $13.04M Feb 27, 2026
FY2024 Dec 31, 2023 $115.22M Feb 21, 2025
FY2023 Dec 31, 2022 $97.05M Feb 20, 2024
FY2022 Dec 31, 2021 $62.53M Feb 17, 2023
FY2021 Dec 31, 2020 ($63.44M) Feb 18, 2022
FY2020 Dec 31, 2019 ($60.92M) Feb 19, 2021
FY2019 Dec 31, 2018 ($74.13M) Feb 14, 2020
FY2018 Dec 31, 2017 ($101.93M) Feb 15, 2019
FY2017 Dec 31, 2016 ($125.13M) Feb 23, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $482.88M Feb 27, 2026
FY2025 Dec 31, 2024 $503.80M Feb 27, 2026
FY2025 Dec 31, 2023 $928.97M Feb 27, 2026
FY2025 Dec 31, 2022 $534.36M Feb 27, 2026
FY2024 Dec 31, 2021 $404.58M Feb 21, 2025
FY2023 Dec 31, 2020 $339.53M Feb 20, 2024
FY2022 Dec 31, 2019 $299.69M Feb 17, 2023
FY2021 Dec 31, 2018 $160.06M Feb 18, 2022
FY2020 Dec 31, 2017 $104.37M Feb 19, 2021
FY2019 Dec 31, 2016 $138.65M Feb 14, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $11.07B Feb 27, 2026
FY2024 Dec 31, 2024 $9.96B Feb 21, 2025
FY2023 Dec 31, 2023 $11.99B Feb 20, 2024
FY2021 Dec 31, 2021 $12.13B Feb 18, 2022
FY2020 Dec 31, 2020 $5.87B Feb 19, 2021
FY2019 Dec 31, 2019 $4.68B Feb 14, 2020
FY2018 Dec 31, 2018 $3.37B Feb 15, 2019
FY2017 Dec 31, 2017 $2.60B Feb 23, 2018
FY2016 Dec 31, 2016 $2.07B Mar 3, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 27, 2026
FY2025 Dec 31, 2024 1 Feb 27, 2026
FY2025 Dec 31, 2023 1 Feb 27, 2026
FY2024 Dec 31, 2022 1 Feb 21, 2025
FY2023 Dec 31, 2021 2 Feb 20, 2024
FY2022 Dec 31, 2020 1 Feb 17, 2023
FY2019 Dec 31, 2019 0 Feb 14, 2020
FY2019 Sep 30, 2019 0 Feb 14, 2020
FY2019 Jun 30, 2019 0 Feb 14, 2020
FY2019 Mar 31, 2019 0 Feb 14, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 27, 2026
FY2025 Dec 31, 2024 1 Feb 27, 2026
FY2025 Dec 31, 2023 1 Feb 27, 2026
FY2024 Dec 31, 2022 1 Feb 21, 2025
FY2023 Dec 31, 2021 2 Feb 20, 2024
FY2022 Dec 31, 2020 1 Feb 17, 2023
FY2019 Dec 31, 2019 0 Feb 14, 2020
FY2019 Sep 30, 2019 0 Feb 14, 2020
FY2019 Jun 30, 2019 0 Feb 14, 2020
FY2019 Mar 31, 2019 0 Feb 14, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 195.49M Feb 27, 2026
FY2025 Dec 31, 2024 189.26M Feb 27, 2026
FY2024 Dec 31, 2023 188.51M Feb 21, 2025
FY2023 Dec 31, 2022 178.23M Feb 20, 2024
FY2021 Dec 31, 2021 151.36M Feb 18, 2022
FY2021 Dec 31, 2020 123.18M Feb 18, 2022
FY2020 Dec 31, 2019 109.71M Feb 19, 2021
FY2019 Dec 31, 2018 83.99M Feb 14, 2020
FY2018 Dec 31, 2017 61.72M Feb 15, 2019
FY2017 Dec 31, 2016 51.40M Feb 23, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $319.95M Feb 27, 2026
FY2025 Dec 31, 2024 $394.84M Feb 27, 2026
FY2025 Dec 31, 2023 $380.64M Feb 27, 2026
FY2024 Dec 31, 2022 $321.74M Feb 21, 2025
FY2023 Dec 31, 2021 $227.06M Feb 20, 2024
FY2022 Dec 31, 2020 $173.11M Feb 17, 2023
FY2021 Dec 31, 2019 $138.80M Feb 18, 2022
FY2020 Dec 31, 2018 $68.08M Feb 19, 2021
FY2019 Dec 31, 2017 $42.61M Feb 14, 2020
FY2018 Dec 31, 2016 $31.80M Feb 15, 2019